Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 7Squamous Cell Carcinoma of Head and Neck 5Oropharyngeal Neoplasms 3Carcinoma, Squamous Cell 2Tongue Neoplasms 1Thyroid Neoplasms 1Radiation Injuries 1Pain, Postoperative 1Pain 1Neoplasms 1Neoplasm Metastasis 1Mucositis 1Mouth Neoplasms 1Carcinoma 1

Interventions

pembrolizumab 156Gemcitabine 140Capecitabine 123Paclitaxel 120Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Leucovorin 97Docetaxel 97Cisplatin 89Radiosurgery 88Irinotecan 87Carboplatin 85Cetuximab 72Cyclophosphamide 71Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Neck Dissection × Clear all
NCT03237195 2018-02-20

Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.

University of Mississippi Medical Center

Completed
139 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡